Edition:
United States

Halyard Health Inc (HYH.N)

HYH.N on New York Stock Exchange

53.47USD
4:02pm EDT
Change (% chg)

$-0.32 (-0.59%)
Prev Close
$53.79
Open
$53.67
Day's High
$53.67
Day's Low
$53.15
Volume
45,257
Avg. Vol
104,473
52-wk High
$54.40
52-wk Low
$35.79

Chart for

About

Halyard Health, Inc. is a medical technology company. The Company provides a portfolio of product offerings focused on pain management, respiratory and digestive health. Its products include post-operative pain management solutions, minimally invasive interventional (or chronic) pain therapies, closed airway suction systems and... (more)

Overall

Beta: 1.66
Market Cap(Mil.): $2,529.02
Shares Outstanding(Mil.): 47.02
Dividend: --
Yield (%): --

Financials

  HYH.N Industry Sector
P/E (TTM): -- 39.23 32.60
EPS (TTM): -0.82 -- --
ROI: -2.13 14.36 12.74
ROE: -3.23 17.21 14.66

BRIEF-Halyard Health Reports Q1 Earnings Per Share $0.43

* HALYARD HEALTH - CASH BALANCE WAS $203 MILLION AT THE END OF QUARTER, COMPARED TO $220 MILLION AT THE END OF 2017 Source text for Eikon: Further company coverage:

May 02 2018

BRIEF-Halyard Health ‍On March 30, Court Reduced Punitive Damages Awarded Against Co To $1.3 Mln Related To Bahamas Surgery Center

* ‍ON MARCH 30, COURT REDUCED PUNITIVE DAMAGES AWARDED AGAINST CO TO $1.3 MILLION RELATED TO BAHAMAS SURGERY CENTER

Apr 02 2018

BRIEF-Halyard Health Q4 Earnings Per Share $0.69

* HALYARD HEALTH, INC. ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2017 RESULTS

Feb 27 2018

BRIEF-Owens & Minor Announces Updates On Pending Acquisition Of Halyard Health's S&IP Business

* OWENS & MINOR ANNOUNCES UPDATES ON PENDING ACQUISITION OF HALYARD HEALTH’S S&IP BUSINESS

Jan 05 2018

BRIEF-Halyard Health Board Approved Initial Phase Of Multi-Year Restructuring Plan

* HALYARD HEALTH-ON DEC 14, BOARD APPROVED INITIAL PHASE OF MULTI-YEAR RESTRUCTURING PLAN FOR DIVESTITURE OF SURGICAL AND INFECTION PREVENTION BUSINESS

Dec 20 2017

Earnings vs. Estimates